Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Vale Q1 Revenues & Earnings Miss Estimates on Lower Iron Ore Prices
Vale Q1 Revenues & Earnings Miss Estimates on Lower Iron Ore Prices

Vale S.A. VALE reported first-quarter 2025 adjusted earnings per share of 35 cents, which missed the Zacks Consensus Estimate of 37 cents. The bottom line marked a 10% decline from earnings of 39

3 Stocks to Watch From Auto Parts Retail Industry With Promising ProspectsPhoto, wide shot, wide-angle lens, soft focus,  Auto parts supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-XjwbnkgTrFCFx6Y3gLbqZBCj.png?st=2023-05-13T09%3A21%3A52Z&se=2023-05-13T11%3A21%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T06%3A55%3A39Z&ske=2023-05-14T06%3A55%3A39Z&sks=b&skv=2021-08-06&sig=wJlbn/o%2BieTjclaQNRsJc%2BDDZieC0UCS6BPi5tapxAA%3D
3 Stocks to Watch From Auto Parts Retail Industry With Promising Prospects
The Zacks Automotive - Retail and Wholesale - Partsindustry is set to benefit from the rising average age of the vehicles that require frequent servicing and replacement of auto parts.Players like
Should You Buy Super Micro Computer Stock Before Q3 Earnings?
Should You Buy Super Micro Computer Stock Before Q3 Earnings?

Super Micro Computer, Inc. SMCI is set to report its third-quarter fiscal 2025 on April 29.

For the fiscal third quarter, the company expects revenues between $5 billion and $6 billion. The Zacks

Invitation Homes to Report Q1 Earnings: What's in Store for the Stock?
Invitation Homes to Report Q1 Earnings: What's in Store for the Stock?

Invitation Homes INVH is slated to report first-quarter 2025 results on April 30, after market close. The company’s quarterly results are likely to display a year-over-year increase in revenues and

Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings?
Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings?

Amazon AMZN is scheduled to report first-quarter 2025 results on May 1.For the first quarter, net sales are expected between $151 billion and $155.5 billion. Net sales are expected to grow 5-9% from

Public Service Enterprise Set to Report Q1 Earnings: What to Expect?
Public Service Enterprise Set to Report Q1 Earnings: What to Expect?

Public Service Enterprise Group Incorporated PEG, or PSEG, is scheduled to report first-quarter 2025 results on April 30, before market open.The company delivered an earnings surprise of 1.20% in

Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Stoke Therapeutics, Inc. (STOK) reports results for the quarter ended March 2025. While this widely-known consensus

Talos Energy (TALO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Talos Energy (TALO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Talos Energy (TALO) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleasePhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known

Gibson Energy Inc. (GBNXF) Expected to Beat Earnings Estimates: Should You Buy?
Gibson Energy Inc. (GBNXF) Expected to Beat Earnings Estimates: Should You Buy?

Wall Street expects a year-over-year decline in earnings on lower revenues when Gibson Energy Inc. (GBNXF) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Earnings Preview: Interparfums (IPAR) Q1 Earnings Expected to Decline
Earnings Preview: Interparfums (IPAR) Q1 Earnings Expected to Decline

Wall Street expects a year-over-year decline in earnings on higher revenues when Interparfums (IPAR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: Should You Buy?
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: Should You Buy?

Hims & Hers Health, Inc. (HIMS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth
Henry Schein (HSIC) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Henry Schein (HSIC) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Analysts Estimate Freshpet (FRPT) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Freshpet (FRPT) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Freshpet (FRPT) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Diamondback Energy (FANG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Diamondback Energy (FANG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Coterra Energy (CTRA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Coterra Energy (CTRA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Coterra Energy (CTRA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Analysts Estimate BWX Technologies (BWXT) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate BWX Technologies (BWXT) to Report a Decline in Earnings: What to Look Out for

The market expects BWX Technologies (BWXT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?
Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

Certara, Inc. (CERT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Analysts Estimate Crescent Energy (CRGY) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Crescent Energy (CRGY) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Crescent Energy (CRGY) reports results for the quarter ended March 2025. While this widely-known consensus outlook is

Corebridge Financial (CRBG) Earnings Expected to Grow: Should You Buy?
Corebridge Financial (CRBG) Earnings Expected to Grow: Should You Buy?

Corebridge Financial (CRBG) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleasePhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

BioCryst Pharmaceuticals (BCRX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus

The Beachbody Company, Inc. (BODI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
The Beachbody Company, Inc. (BODI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

The market expects The Beachbody Company, Inc. (BODI) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known

BellRing Brands (BRBR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
BellRing Brands (BRBR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Wall Street expects a year-over-year increase in earnings on higher revenues when BellRing Brands (BRBR) reports results for the quarter ended March 2025. While this widely-known consensus outlook

Freightcar America (RAIL) Earnings Expected to Grow: Should You Buy?
Freightcar America (RAIL) Earnings Expected to Grow: Should You Buy?

Freightcar America (RAIL) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook

Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline
Earnings Preview: Axsome Therapeutics (AXSM) Q1 Earnings Expected to Decline

The market expects Axsome Therapeutics (AXSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus